BioSpace News Archive

Deals

Catalent Announces Launch of Private Offering of $450 Million of Senior Unsecured Notes Due 2030

Catalent, Inc. today announced that its wholly owned subsidiary, Catalent Pharma Solutions, Inc. (the “Operating Subsidiary”), intends to offer, subject to market and other conditions, $450 million in aggregate principal amount of senior unsecured notes due 2030

September 23, 2021
·
6 min read
BioCapital

Gain Therapeutics to Present at the Cantor Virtual Global Healthcare Conference

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), today announced that Eric Richman, Chief Executive Officer of Gain Therapeutics, will present at the Cantor Virtual Global Healthcare Conference.

September 23, 2021
·
3 min read
Nanox to Present at the Cantor Fitzgerald Global Healthcare Conference

NANO-X IMAGING LTD, an innovative medical imaging technology company, announced that Nanox’s Chairman and Chief Executive Officer, Ran Poliakine, and Executive Chairman, Erez Meltzer, will make a company presentation at the Cantor Fitzgerald Global Healthcare Conference.

September 23, 2021
·
1 min read
Drug Development

Novan Reports Safety Data from B-SIMPLE4 Pivotal Phase 3 Study of SB206

Novan, Inc., announced the comprehensive safety data readout as part of the Company’s B-SIMPLE4 pivotal Phase 3 study of SB206 for the treatment of molluscum contagiosum.

September 23, 2021
·
7 min read
Genetown

Host Genetic Backgrounds Underlie Variable COVID-19 Pathology

Mice with different genetic backgrounds exhibit highly variable responses to SARS-CoV-2 infection, mirroring the large differences in COVID-19 disease severity seen in humans.

September 23, 2021
·
5 min read
Business

Adaptive Phage Therapeutics Appoints Michele Wales, Ph.D., J.D., as Chief Legal Officer

Adaptive Phage Therapeutics, Inc. today announced that it has appointed Michele Wales, Ph.D., J.D., as Chief Legal Officer. Dr. Wales joins APT with extensive experience in litigation and intellectual property law, specifically within the life sciences industry.

September 23, 2021
·
2 min read
Drug Development

Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin’s Broad-Spectrum Antiviral Properties

Innovation Pharmaceuticals today provided an update on the status of its randomized, double-blind, placebo-controlled Phase 2 clinical trial of Brilacidin for the treatment of moderate-to-severe COVID-19 in hospitalized patients

September 23, 2021
·
6 min read
Business

Twist Bioscience Collaborates with Deep Learning Experts deepCDR on Antibody Library Design

Twist Bioscience Corporation today announced a collaboration with deepCDR, a private company focused on applying deep learning algorithms to antibody discovery and optimization.

September 23, 2021
·
4 min read
Pharm Country

UroGen Pharma to Present at the 2021 Cantor Virtual Global Healthcare Conference

UroGen Pharma Ltd. today announced that it will present at the Cantor Fitzgerald 2021 Virtual Global Healthcare Conference on Thursday, September 30, 2021, at 3:20 p.m. Eastern Time.

September 23, 2021
·
1 min read
Biotech Bay

Pear Therapeutics Announces Additional Coverage Decisions and Formulary Adoption of its Prescription Digital Therapeutics

Pear Therapeutics, Inc. today updated the number of entities providing coverage for its three commercial products, reSET®, reSET-O®, and Somryst®.

September 23, 2021
·
11 min read